These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 36029939
1. Elucidation of lactose fine size and drug shape on rheological properties and aerodynamic behavior of dry powders for inhalation. Sun Y, Yu D, Li J, Zhao J, Feng Y, Zhang X, Mao S. Eur J Pharm Biopharm; 2022 Oct; 179():47-57. PubMed ID: 36029939 [Abstract] [Full Text] [Related]
2. Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation. Sun Y, Qin L, Li J, Su J, Song R, Zhang X, Guan J, Mao S. AAPS J; 2021 Apr 15; 23(3):55. PubMed ID: 33856568 [Abstract] [Full Text] [Related]
3. Synergistic effect of magnesium stearate and fine lactose in improving aerosolization performance of fluticasone propionate in dry powder formulation. He X, Li J, Wen X, Ma S, An Y, Zhang X, Guan J, Mao S. Int J Pharm; 2024 Oct 25; 664():124609. PubMed ID: 39163928 [Abstract] [Full Text] [Related]
4. Exploring the potential influence of drug charge on downstream deposition behaviour of DPI powders. Sun Y, Cui Z, Sun Y, Qin L, Zhang X, Liu Q, Shen X, Yu D, Mao S. Int J Pharm; 2020 Oct 15; 588():119798. PubMed ID: 32828976 [Abstract] [Full Text] [Related]
5. Exploring the influence of magnesium stearate content and mixing modality on the rheological properties and in vitro aerosolization of dry powder inhaler. Li J, Ma S, He X, Sun Y, Zhang X, Guan J, Mao S. Int J Pharm; 2023 Jul 25; 642():123179. PubMed ID: 37364785 [Abstract] [Full Text] [Related]
6. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate. Mönckedieck M, Kamplade J, Fakner P, Urbanetz NA, Walzel P, Steckel H, Scherließ R. Int J Pharm; 2017 May 30; 524(1-2):351-363. PubMed ID: 28347847 [Abstract] [Full Text] [Related]
7. Exploring the influence of drug content on DPI powder properties and potential prediction of pulmonary drug deposition. Sun Y, Qin L, Liu C, Su J, Zhang X, Yu D, Guo C, Lu H, Li L, Xiong W, Mao S. Int J Pharm; 2020 Feb 15; 575():119000. PubMed ID: 31893544 [Abstract] [Full Text] [Related]
8. Powder flow analysis: A simple method to indicate the ideal amount of lactose fines in dry powder inhaler formulations. Hertel M, Schwarz E, Kobler M, Hauptstein S, Steckel H, Scherließ R. Int J Pharm; 2018 Jan 15; 535(1-2):59-67. PubMed ID: 29100914 [Abstract] [Full Text] [Related]
17. Surface Modification of lactose carrier particles using a fluid bed coater to improve fine particle fraction for dry powder inhalers. Gong QQ, Tay JYS, Veronica N, Xu J, Heng PWS, Zhang YP, Liew CV. Pharm Dev Technol; 2023 Feb 01; 28(2):164-175. PubMed ID: 36683577 [Abstract] [Full Text] [Related]